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OBJECTIVE: To create evidence-based clinical practice
guidelines based on a systematic review of published
literature regarding the risks and benefits of available
preoperative, intraoperative, and postoperative technical
steps and interventions at the time of vaginal hysterec-
tomy for benign indications.
DATA SOURCES: We systematically searched the litera-
ture to identify studies that compared technical steps or
interventions during the preoperative, intraoperative, and
postoperative periods surrounding vaginal hysterectomy.
We searched MEDLINE, Cochrane Central Register of
Controlled Trials, Health Technology Assessments, and
ClinicalTrials.gov from their inception until April 10, 2016,
using the MeSH term “Hysterectomy, Vaginal” and associ-
ated text words. We included comparative studies, single-
group studies, and systematic reviews published in English.
METHODS OF STUDY SELECTION: We double-
screened 4,250 abstracts, identifying 60 eligible stud-
ies. Discrepancies were adjudicated by a third
reviewer. We followed standard systematic review
methodology and the Grades for Recommendation,
Assessment, Development and Evaluation approach to
evaluate the evidence and generate guideline recom-
mendations.
TABULATION, INTEGRATION, AND RESULTS: Because
of limited literature, only 16 perioperative risks, technical
steps, and interventions were identified: obesity, large
uteri, prior surgery, gonadotropin-releasing hormone
agonists, vaginal antisepsis, bilateral salpingo-
oophorectomy, morcellation, apical closure, uterine
sealers, hemostatic injectants, hot cone, retractor,
cystoscopy, vaginal packing, bladder management,
and accustimulation. We organized and reported
these as four domains: patient selection, preopera-
tive, intraoperative, and postoperative. We did not
identify any patient characteristics precluding a vaginal
approach; chlorhexidine or povidone is appropriate
for vaginal antisepsis; vasopressin decreases blood
loss by 130 cc; tissue-sealing devices decrease blood
loss by 44 cc and operative time by 15 minutes with
uncertain complication implications; vertical cuff clo-
sure results in 1-cm increased vaginal length; either
peritoneum or epithelium can be used for colpotomy
closure; and routine vaginal packing is not advised.
CONCLUSION: Minimal data exist to guide surgeons
with respect to planning and performing a vaginal
hysterectomy. This study identifies available information
and future areas for investigation.
(Obstet Gynecol 2017;129:877–86)
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Hysterectomy is one of the most frequently per-formed surgeries in the United States, with more
than 400,000 hysterectomies performed annually.1,2 A
systematic review of 47 randomized controlled trials
(RCTs) including 5,102 hysterectomies concluded
that a vaginal approach is the safest and most cost-
effective route of hysterectomy.3 Congruent with
these findings, the American College of Obstetricians
and Gynecologists recommends a vaginal approach as
the preferred route of hysterectomy.4 Despite this rec-
ommendation, the proportion of hysterectomies per-
formed vaginally has steadily decreased from 25% in
1998 to 17% in 2010.2
Gynecologists have cited potential complications,
technical difficulties, lack of experience, and low-
volume caseload as barriers to performing a vaginal
hysterectomy.5 These barriers, in part, may be ad-
dressed with increased knowledge about the factors
associated with success and failure of a vaginal
approach. In addition, our systematic review of the
literature (described in the next paragraph) did not
identify any published clinical practice guidelines to
direct surgeons on how to perform a vaginal hyster-
ectomy. With these barriers in mind, the Society of
Gynecologic Surgeons Systematic Review Group per-
formed a systematic review to create an evidence-
based clinical practice guideline that addresses the
relative risks and benefits of available preoperative,
intraoperative, and postoperative technical steps and
interventions at the time of vaginal hysterectomy for
benign indications.
SOURCES
The Society of Gynecologic Surgeons Systematic
Review Group includes members with clinical and
surgical expertise on performing vaginal hysterec-
tomy and in the conduct of systematic review and
guideline development. We systematically searched
the literature to identify studies comparing technical
step options and interventions during the preopera-
tive, intraoperative, and postoperative periods sur-
rounding a vaginal hysterectomy. We followed
standard systematic review methodology and the
Grades for Recommendation, Assessment, Develop-
ment and Evaluation approach to evaluate the evi-
dence for guideline recommendations.6,7 We searched
MEDLINE, Cochrane Central Register of Controlled
Trials, Health Technology Assessments, and Clinical-
Trials.gov from their inception until April 10, 2016.
We used a broad search strategy to identify all tech-
nical steps and interventions that had been assessed.
Our search included all studies related to the MeSH
term “Hysterectomy, Vaginal” and associated text
words. The search was limited to English language
and comparative studies, single-group studies, and
systematic reviews.
STUDY SELECTION
We included studies reporting on vaginal hysterec-
tomy for benign indications. We excluded studies that
did not separately report data for vaginal hysterec-
tomy alone and studies that compared vaginal hyster-
ectomy with another route of hysterectomy.
Interventions of interest included any technical
step, intervention, or decision related to the perfor-
mance of a vaginal hysterectomy, including technical
surgical aspects or management in the preoperative
and postoperative period, or patient characteristics
that may be considered traditional barriers to per-
forming a vaginal hysterectomy. Comparators of
interest included any alternate treatment methods.
Included studies had to report intraoperative out-
comes (eg, surgical time, estimated blood loss) or
postoperative outcomes (eg, vaginal length, pain,
nausea, and length of hospital stay).
Citations from the search were screened for
eligibility by 11 reviewers using Abstrackr (http://ab-
strackr.cebm.brown.edu/).8 To establish relevance
and consensus among reviewers, all 11 reviewers
screened 150 abstracts. Once consensus was assured,
all remaining abstracts were independently screened
in duplicate with discrepancies adjudicated by a third
reviewer. Potentially relevant full-text articles were
then independently reviewed and double-screened
by 10 reviewers, who extracted data from all included
studies.
We extracted data on study characteristics, par-
ticipant characteristics, funding source, intervention
details, length of follow-up, outcomes of interest, and
how the outcomes were assessed. After data extrac-
tion, we categorized all interventions into the follow-
ing four domains: 1) preoperative, 2) intraoperative,
3) postoperative, and 4) patient selection factors.
These interventions are listed in Table 1.
The methodologic quality (or risk of bias) of each
study was assessed with the Cochrane risk of bias tool
for RCTs and selected questions from the Newcastle-
Ottawa Scale for observational studies.9,10 The overall
quality of each study was then categorized as good
(A), fair (B), or poor (C). Each study outcome was also
assessed for possible downgrading of quality because
of outcome-specific concerns.6 An evidence profile
was generated for each intervention category (eg, vag-
inal preparation, hemostatic injection) by grading the
quality of evidence for each outcome (eg, estimated
blood loss, length of hospital stay) across studies.6,11
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We considered methodologic quality, consistency of
results across studies, directness of evidence, and
other factors such as imprecision or sparseness of evi-
dence to determine an overall quality of evidence in
accordance with the Grades for Recommendation,
Assessment, Development and Evaluation system.
The overall strength of evidence for each outcome
was categorized as high, moderate, low, or insuffi-
cient.6,11 For outcomes with two or less studies or if
we were unable to find an association or effect (gen-
erally because of imprecision or inconsistency across
studies), we determined that the evidence was
“insufficient.”
We developed recommendation statements incor-
porating the balance between benefits and harms of
the compared interventions when there was sufficient
Table 1. Evidence for Comparative Outcomes
Domain Intervention or Factor
Strength
of Evidence No. of Studies
Total No.
of Participants
Patient selection* Obesity Low 3 1,131
Obese patients have longer operative times, higher EBL and transfusion rates; no increase in risk of
complications or hospital stay
Traditional contraindications* Low 2 920
No differences in hospital stay, operative time, time to regular diet, hematocrit, transfusion rate, febrile
morbidity, cystitis, urinary tract injury, or overall complication rates
Preoperative Gonadotropin-releasing hormone Insufficient 1 50
Gonadotropin-releasing hormone agonists increased the number of hysterectomies completed vaginally without
differences in uterine weight or transfusion rates
Vaginal antisepsis Low 2 83
No difference in incidence of postoperative vaginal infections
Intraoperative Bilateral salpingo-oophorectomy Low 3 1,216
No increase in estimated blood loss, complications, or length of stay; oophorectomy is likely associated with
longer operative time
Morcellation Low 3 2,432
There are no substantial harms associated with morcellation, but operative time is increased
Apical closure technique Low 3 202
Vertical cuff closure results in slight increase in vaginal length
Peritoneal closure Low 5 363
There are no benefits or harms to closing the peritoneum
Tissue sealer vs conventional ligation Moderate 15 1,389
Tissue sealer devices may decrease operative time and blood loss compared with traditional suture ligation with
unknown complication risks
Hemostatic injectants Low 5 345
Vasopressin appears to decrease blood loss with no difference in infections, operative time, or hospital stay
Hormone (estrogen) Insufficient 1 269
Estrogen may improve wound healing
Hot cone Insufficient 1 402
Cervical cautery may decrease infection rates if preoperative antibiotics are not available
Retractor Insufficient 1 213
Self-retaining retractors may work as well as a surgical assistant
Cystoscopy Insufficient 1 593
Cystoscopy does not demonstrate a difference in ureteral injury identification or costs
Postoperative Vaginal packing Moderate 3 395
There are no apparent net benefits to vaginal packing
Bladder management Insufficient 5 369
Various interventions and outcomes were evaluated resulting in insufficient data and inability to provide useful
recommendations.
Vaginal Drain Insufficient 1 272
There are no net benefits to placing a vaginal drain.
Postoperative recovery Insufficient 2 300
Standardized protocols improve postoperative recovery; accustimulation may decrease nausea and vomiting
EBL, estimated blood loss.
* Patient selection: characteristics that may be considered barriers to performing a vaginal hysterectomy such as prior laparotomy or
cesarean delivery, nulliparity, or large uterus.
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evidence (of high, moderate, or low strength) to
support these statements. Each recommendation state-
ment was assigned a strength of recommendation (1
—“strong” or 2—“weak”) based on the quality of the
supporting evidence and the magnitude of the net med-
ical benefit (benefits compared with harms) to indicate
the confidence that adherence to the recommendation
will do more good than harm. We presented our find-
ings at the Society of Gynecologic Surgeons Annual
Scientific Meeting in April 2016. The draft guideline
was made available to the entire Society of Gyneco-
logic Surgeons membership for review for 10 days after
public presentation and to the Society’s executive com-
mittee for final approval. Feedback from Society of
Gynecologic Surgeons members and leadership was
incorporated into the final recommendations.
RESULTS
The literature search identified 4,250 abstracts; 264
full-text papers were retrieved and assessed in detail
(Fig. 1). In total, 60 studies were eligible and included
in this review. We categorized the studies into 18 in-
terventions, as outlined in Table 1 and Appendices 1–
15 (appendices available online at http://links.lww.
com/AOG/A944).
The Society of Gynecologic Surgeons Systematic
Review Group developed an evidence-based clinical
practice guideline for performing vaginal hysterec-
tomy with specific recommendations (Box 1) when
there is sufficient evidence to warrant recommenda-
tions. To reiterate, each recommendation received
a strength of recommendation (15strong, “we recom-
mend” or 25weak, “we suggest”) and overall strength
of evidence (high [A] to low [C]). Most of the recom-
mendations were graded as 2B or 2C, indicating that
existing evidence supports suggestions that the major-
ity of patients and clinicians would want to follow but many would not. Clinical judgment is needed for
these suggestions because physicians must evaluate
the particular needs of each patient to arrive at the
best management decision for that patient. From a pol-
icymaking standpoint, additional evidence is needed
for most aspects of a vaginal hysterectomy before
a policy statement could be made on “best” perfor-
mance of a vaginal hysterectomy.
Seven studies examined patient characteristics
that may be considered barriers to performing
a vaginal hysterectomy (n53,259) consisting of poor
(five studies12–16) or fair (two studies17,18) quality.
Comparing subpopulations of women undergoing
vaginal hysterectomy with characteristics that may
be considered barriers to vaginal hysterectomy (ie,
prior laparotomy, cesarean delivery, nulliparity, or
uterus greater than 180 g) with women without these
Fig. 1. Flow diagram showing study selection.
Jeppson. Vaginal Hysterectomy Systematic Review. Obstet Gynecol
2017.
Box 1. Vaginal Hysterectomy Clinical Practice
Guidelines
Patient selection
 We suggest the following factors need not be de-
terrents to attempting a transvaginal approach
(grade 2C):
∘ Obesity
∘ Prior cesarean delivery or other laparotomy
∘ Nulliparity
∘ Planned concomitant bilateral salpingo-
oophorectomy
∘ Enlarged uterus
Preoperative
 We suggest either 4% chlorhexidine or povidone
for vaginal surgical site antisepsis (grade 2B).
Intraoperative
 We suggest injecting vasopressin intracervically at
the start of vaginal hysterectomy to decrease blood
loss (grade 2B).
 We suggest using tissue sealing devices to limit
blood loss and shorten operative time, but these
benefits should be balanced against the potential
risk of thermal complications and uncertain cost
implications (grade 2B).
 If postoperative vaginal length is a concern, we
suggest vertical cuff closure at the time of vaginal
hysterectomy (grade 2B).
 We suggest that either peritoneum or vaginal epi-
thelium can be used for colpotomy closure (grade
2C).
Postoperative
 We recommend against the routine use of vaginal
packing for improvement in postoperative pain,
bleeding, or infections (grade 1B).
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characteristics, no difference was observed in length
of hospital stay (low strength of evidence).13,16
Three studies compared intraoperative and post-
operative outcomes in nonobese and obese patients
undergoing vaginal hysterectomy; nonobese patients
had shorter operative times (moderate strength of
evidence) and less intraoperative estimated blood loss
and perioperative transfusions (low strength of evi-
dence).14,15,17 However, obesity was not associated
with increased duration of hospital stay or increased
risk of complications (ie, reoperation, viscus injury,
venous thromboembolism, or urinary retention; low
strength of evidence). There was insufficient evidence
regarding febrile morbidity and postoperative cystitis.
No absolute contraindications to vaginal hysterec-
tomy were identified.
Only one study, of good quality, compared pre-
operative gonadotropin-releasing hormone therapy with
no therapy (n550).19 Women with symptomatic 14–18
weeks-sized fibroid uteri planning hysterectomy
received 8 weeks of preoperative therapy compared
with no therapy. A greater proportion of women who
received therapy had their hysterectomies completed
vaginally (low strength of evidence). There were no dif-
ferences in final uterine weight, transfusion rates, or
postoperative hematocrit levels (low strength of evi-
dence). Data are lacking on complications associated
with 8 weeks of agonist therapy. There is not enough
data to recommend for or against gonadotropin-
releasing hormone therapy before vaginal hysterectomy.
Three studies compared uterine morcellation with
intact uterine extirpation at the time of vaginal hyster-
ectomy (n52,432) of poor (two studies20,21) or fair (one
study22) quality. There was no difference in bladder
injury or postoperative febrile morbidity (both moder-
ate strength of evidence), postoperative transfusion or
other bleeding-related outcomes, conversion to laparot-
omy, or length of hospital stay (all low strength of evi-
dence); however, operative time increased with
morcellation (low strength of evidence). We did not
identify any articles commenting on the risk of leiomyo-
sarcoma at the time of vaginal hysterectomy and cannot
comment on that risk. Based on the studies included,
there were no significant risks identified for uterine
morcellation at the time of vaginal hysterectomy.
Two studies compared vaginal cleaning solutions
before vaginal hysterectomy (n583) with good23 and
poor24 study quality. One study (n550) compared
povidone–iodine with chlorhexidine23 and the other
(n533) compared povidone–iodine with a saline
solution.24 There was no difference in postoperative
vaginal infection rates among chlorhexidine, povi-
done, and saline. The study that compared povidone–
iodine with chlorhexidine used a surrogate of bacterial
load after vaginal cleaning with a significantly lower
number of bacteria present in the chlorhexidine group
(high strength of evidence). The results of povidone
compared with saline should be interpreted with
caution because all patients in that study received 24
hours of postoperative prophylactic antibiotics (low
strength of evidence).24 There were no adverse events
reported, including mucosal irritation or contact der-
matitis, for the women who received chlorhexidine.
There were no identified risks for the routine use of
vaginal antisepsis at the time of vaginal hysterectomy.
Three studies compared surgical outcomes for
bilateral salpingo-oophorectomy (BSO) compared
with no BSO at the time of vaginal hysterectomy
(n51,216) with poor study quality.25–27 They found
no difference in hospital length of stay or periopera-
tive complications, including transfusion (low-quality
evidence). Concurrent BSO increases surgical time by
2–23 minutes (low strength of evidence). Concurrent
BSO does not seem to appreciably increase surgical
risk at the time of vaginal hysterectomy.
Three studies compared vertical with horizontal
cuff closure (n5202) in vaginal hysterectomy without
concomitant apical suspension with good28,29 and
poor30 study quality. Vertical cuff closure (ie, ending
with a vertical repair line of the epithelial scar) demon-
strated 1-cm longer vaginal length 6 weeks after sur-
gery compared with horizontal closure, but the clinical
significance of this difference is unclear and patient-
centered outcomes (ie, dyspareunia, prolapse) were
not reported.28,29 Closure technique did not demon-
strate any difference in operative time, blood transfu-
sion, or cuff cellulitis (moderate strength of evidence).
Five studies compared intracervical injection of
vasopressin with normal saline or no injection at the
beginning of vaginal hysterectomy (n5345) with
good,31,32 fair,33,34 and poor35 study quality. Com-
pared with women in a control group, vasopressin
decreased estimated blood loss by approximately
130 cc with higher postoperative hematocrit (1–2%;
moderate-quality evidence); there was no difference in
incidence of vaginal cuff infection (moderate-quality
evidence), operative time (low-quality evidence), or
hospital length of stay (high-quality evidence).
Vasopressin may cause temporary elevations in blood
pressure and increased postoperative narcotic use
(low-strength evidence). Overall, the benefits of intra-
cervical injections of vasopressin at the start of vaginal
hysterectomy may outweigh the potential harms
(moderate strength of evidence), but a 2% difference
in postoperative hematocrit is probably not clinically
significant under most circumstances.
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Fifteen studies examined the use of a tissue
sealing, stapling, or suturing device compared with
traditional clamping and suture ligation during vagi-
nal hysterectomy (n51,389). The number of study
participants per trial ranged from 1036 to 200,37 and
study qualities were good,38–43 fair,44,45 and
Table 2. Vaginal Hysterectomy Interventions With Insufficient Evidence
Intervention
No. of
Studies Study Details
Patient selection 1 Numerous outcomes were assessed by only one study each; insufficient evidence
regarding operative time, time to resumption of regular diet, change in hematocrit,
transfusion rate, febrile morbidity, postoperative cystitis, injury to lower urinary tract,
or overall complication rates12,13,16,18
Bilateral salpingo-
oophorectomy
1 Insufficient evidence is available to comment on factors associated with successful
completion of BSO59
Peritoneal closure 5 Five studies evaluated peritoneal closure (n5363) with fair60–63 and poor64 study
quality; three studies compared only closing peritoneum with only closing vaginal
epithelium (n5207) 60,62,64; overall, no difference was seen in complications between
groups with the exception of one study that intentionally left a small portion of the
peritoneum open to drain, which reported one fallopian tube prolapse and one bowel
evisceration62; all of these studies were underpowered for both their primary and
secondary outcomes; there is insufficient evidence to recommend for or against
adding peritoneal closure when closing the vaginal cuff
Tissue sealers 2 One study evaluated the Multifire Endo-GIA stapler compared with traditional suture
ligation (n510)46; another study compared an aneurysm needle suture technique with
traditional suturing (n546)37; based on the limited data regarding these techniques,
reliable conclusions cannot be made
Bladder function 3 Three studies evaluated pharmacologic agents on postoperative voiding dysfunction65–
67; prostaglandin E2 may decrease febrile morbidity, duration of catheter use, and
length of hospital stay (insufficient evidence); prostaglandin F2a´ did not demonstrate
any benefit (insufficient evidence); oral a-adrenergic blockers may decrease
postoperative urinary retention (insufficient evidence); there is insufficient evidence to
recommend the routine use of medical management to facilitate Foley catheter
removal
Hormone 1 Compared transdermal systemic estrogen with local vaginal estrogen on wound healing
and infection68; possible improved wound healing in both estrogen groups
Hot cone 1 “Hot cone” refers to removing the central portion of the cervix with cautery to help with
antisepsis, not dysplasia; three-armed study evaluated the effect of cervical conization
with cautery on postoperative infection; the cautery group demonstrated similar
infection rates with the antibiotic group and much lower infection rates than the no
antibiotic group69
Retractor 1 Compared a self-retaining retractor with standard assistant retraction without any
between-group differences in surgical time or estimated blood loss70
Cystoscopy 1 Compared routine cystoscopy with no cystoscopy at the time of vaginal hysterectomy
with similar ureteral injuries and costs between groups71
Vaginal drain 1 Compared placement of a vaginal vault drain with no drain; no difference noted with
respect to febrile morbidity, hospital readmission, blood transfusion, postoperative
hematocrit change, or length of hospital stay72
Postoperative recovery:
recovery protocol
1 Compared a standardized recovery protocol with routine care in a population of women
undergoing vaginal hysterectomy73; the standardized protocol decreased use of
vaginal packing, duration of catheter, and overall length of hospital stay
Postoperative recovery:
accustimulation
1 Accustimulation is a practice of applying mild electrical stimulation to acupuncture
sites; compared the inclusion of accustimulation with routine care with decreased
nausea and vomiting in the accustimulation group74
BSO, bilateral salpingo-oophorectomy.
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poor.36,37,46–50 Eight studies evaluated the Liga-
sure,36,38–40,43,44,48,50 and four examined other similar
bipolar clamps.42,45,47,49 One study evaluated ultrasonic
shears compared with traditional suture ligation
(n543).41 Narcotic analgesia use, length of hospital
stay, hysterectomy time, and total operative time were
similar in both groups (high strength of evidence).
Estimated blood loss was less in the ultrasonic shears
group without a difference in postoperative hemoglo-
bin change (moderate strength of evidence). Two
additional studies that reported on different surgical
products are included in Table 2.
Bipolar tissue sealer instruments resulted in
15 minute shorter operative times (high strength of
evidence) and 44 mL less intraoperative estimated
blood loss (moderate strength of evidence) than
conventional suturing with no other significant differ-
ences between groups (moderate strength of evi-
dence). Subsequently, there do not appear to be any
net benefits for one method (moderate strength of
evidence) with the exception of surgical time favor-
ing tissue sealers (high strength of evidence). How-
ever, this benefit should be weighed against device
cost and unclear complication risks because none of
the studies was adequately powered to evaluate for
rare adverse events.
Three RCTs compared vaginal packing with no
packing in a population of women undergoing vaginal
hysterectomy (n5395) with good study quality.51–53
There were no apparent net benefits to vaginal pack-
ing for postoperative pain, satisfaction, bleeding, or
infections (moderate strength of evidence). In addi-
tion, vaginal packing did not have an effect on the
presence of a cuff hematoma 6 weeks after surgery
(low strength of evidence). There were no identified
benefits for the use of routine vaginal packing at the
time of vaginal hysterectomy.
Two studies compared catheter management after
vaginal hysterectomy.54,55 Early removal of a bladder
catheter decreases febrile morbidity and length of stay
but may result in catheter replacement (low-quality
evidence). All remaining interventions have insuffi-
cient evidence and are reported in Table 2.
DISCUSSION
This systematic review provides evidence to support
several vaginal hysterectomy clinical practice guide-
lines. We have listed these in Box 1. This study also
highlights the areas of limited data and may facilitate
hypothesis generation by identifying additional areas
where future investigation may be helpful (Table 3).
We developed an a priori list of interventions and
patient factors to consider when planning a vaginal
hysterectomy and included additional interventions
that were identified in eligible studies. However, we
found comparative evidence for only a subset of these
interventions and adequate (“sufficient”) evidence for
a small subset of those comparisons. To improve
evidence-based decision-making, future studies are
needed for a wide range of interventions and are listed
in Table 3. Only the recommendation against routine
postoperative vaginal packing rose to level 1 (specifi-
cally 1B), indicating that the risks of postoperative
vaginal packing generally outweigh the benefits for
most patients.
We identified two prior systematic reviews that
evaluated electrosurgical vessel sealing for vaginal
hysterectomy.56,57 Similar to our findings, Kroft
et al56 found shorter operative times and lower esti-
mated blood loss with the use of vessel sealing devices
compared with conventional suturing. In contrast to
our study, however, these authors found improved
postoperative hematocrit levels, reduced patient-
reported pain, and shorter hospital stay. A second
systematic review by Pergialiotis et al57 reported
lower estimated blood loss but no difference in oper-
ative time with electrosurgical bipolar instruments.
The discrepancies between the prior systematic re-
views and our systematic review are likely attributable
to our inclusion of a broader range of studies. The
prior systematic reviews were restricted to seven and
eight RCTs, respectively.56,57 In contrast, we also
included nonrandomized comparative studies for
a total of 15 studies (of electrosurgical vessel sealing),
Table 3. Areas Lacking for Guidance of Vaginal
Hysterectomy
Timing Interventions*
Preoperative Preoperative bowel preparation,
prophylactic antibiotics,treatment of
bacterial vaginosis, thromboprophylaxis
Intraoperative Patient positioning, surgeon positioning,
general vs spinal anesthesia
Surgical
techniques
Blunt vs sharp dissection, colpotomy
techniques, retractor use, vaginal
morcellation techniques
Immediate
postoperative
Routine hemoglobin and hematocrit or
chemistry laboratory panels
Long-term
postoperative
Sexual function, chronic pain, vaginal
prolapse, urinary incontinence, quality of
life, patient satisfaction
* Various study types (including comparative cohorts, randomized
controlled trials, and case–control studies) could be used to
provide additional information on these interventions.
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10 of which were RCTs. We also included other ves-
sel sealing technologies including bipolar, ultrasonic,
and stapling, whereas the prior reviews only included
bipolar devices.
This review has several strengths including
robust methodology and utilization of clear, repro-
ducible practice guideline development based on
evidence-based clinical data. This review was per-
formed by experienced reviewers using an updated
systematic review methodology, allowing us to
combine and grade evidence from different study
types.6 This methodology allows surgeons and pa-
tients to interpret and make personal decisions
about risks and benefits of technical steps and in-
terventions at the time of vaginal hysterectomy.6
This systematic review is limited by the available
evidence in the medical literature on interventions
to facilitate optimal outcomes after vaginal hyster-
ectomy. We have presented all available studies in
this area and highlighted gaps in the evidence
(Table 3) that may help researchers formulate
future research studies on this important topic.
One limitation of this practice guideline is that
we restricted our search to studies specifically
related to vaginal hysterectomy. For example, the
Centers for Disease Control and Prevention pub-
lished a systematic review with very robust data,
which essentially recommends minimizing urinary
catheter use and duration for all patients. The
results of our study support those findings but are
based on very sparse data because only two studies
were included in this systematic review specific to
the use of an indwelling catheter at the time of
a vaginal hysterectomy.58 Standard medical man-
agement and surgical techniques from broad med-
ical literature and surgeon experience should be
used for decision-making in areas that are not well
addressed by this review such as minimizing uri-
nary catheter use and decisions about vaginal hys-
terectomy with concomitant pelvic reconstruction.
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